We are live on ! Find out more
WE

Wealth Effects Portfolio holdings

AUM $282M
1-Year Est. Return 62.81%
This Fund
S&P 500
This Quarter Est. Return
+5.44%
1 Year Est. Return
+62.81%
3 Year Est. Return
+160.11%
5 Year Est. Return
10 Year Est. Return
AUM
$241M
AUM Growth
Cap. Flow
+$245M
Cap. Flow %
101.71%
Top 10 Hldgs %
38.78%
Holding
215
New
215
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
AVDL
Avadel Pharmaceuticals
AVDL
+$21.1M
2
AAPL icon
Apple
AAPL
+$17.2M
3
ARWR icon
Arrowhead Research
ARWR
+$10M
4
AMZN icon
Amazon
AMZN
+$10M
5
NVDA icon
NVIDIA
NVDA
+$7.41M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 26.05%
2 Healthcare 24.9%
3 Communication Services 10.01%
4 Financials 9.77%
5 Consumer Discretionary 6.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GGT
201
Gabelli Multimedia Trust
GGT
$173M
$167K 0.07%
+19,491
New +$176K
MYD
202
DELISTED
BlackRock MuniYield Fund
MYD
$160K 0.07%
+10,875
New +$158K
PCT icon
203
PureCycle Technologies
PCT
$1.21B
$156K 0.06%
+16,250
New +$196K
BFX
204
DELISTED
BowFlex Inc.
BFX
$141K 0.06%
+23,050
New +$191K
ICCC icon
205
ImmuCell
ICCC
$101M
$127K 0.05%
+15,850
New +$142K
FXN icon
206
First Trust Energy AlphaDEX Fund
FXN
$393M
$125K 0.05%
+10,500
New +$130K
AUTL
207
Autolus Therapeutics
AUTL
$383M
$119K 0.05%
+22,950
New +$138K
IMDX
208
Insight Molecular Diagnostics
IMDX
$153M
$94K 0.04%
+2,175
New +$125K
ET icon
209
Energy Transfer Partners
ET
$69.9B
$88K 0.04%
+10,672
New +$97K
ATAXZ
210
DELISTED
AMERICA FIRST TAX EXEMT INV LP
ATAXZ
$74K 0.03%
+11,500
New +$74K
CURI icon
211
CuriosityStream
CURI
$152M
$68K 0.03%
+11,550
New +$97.3K
AMRN
212
Amarin Corp
AMRN
$292M
$67K 0.03%
+1,000
New +$82.8K
ATHX
213
DELISTED
Athersys, Inc. Common Stock
ATHX
$65K 0.03%
+2,860
New +$82K
BEST
214
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$22K 0.01%
+1,275
New +$34.5K
CATX icon
215
Perspective Therapeutics
CATX
$341M
$4K ﹤0.01%
+1,000
New +$5.33K

Similar funds

Wealth Effects's Q4 2021 Portfolio in Review

Q4 2021 is the first quarter with a 13F filing on record for Wealth Effects, which disclosed 215 positions worth $241M. Its ten largest holdings account for 39% of the portfolio.

Its largest position is Avadel Pharmaceuticals: 2,305,017 shares worth $18.6M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, followed by Healthcare and Communication Services.

  • Wealth Effects's largest Q4 2021 buy was Avadel Pharmaceuticals: 2,305,017 shares worth $18.6M.
  • Wealth Effects's ten largest holdings make up 39% of its $241M portfolio in Q4 2021.
  • Wealth Effects disclosed 215 positions in Q4 2021, its first 13F filing on record.

Based on Wealth Effects's 13F filing for Q4 2021, filed 9 Feb 2022.